Profilo
Nils Martin Malmsten is the founder of DermaGen AB (founded in 2004) and Sista versen 26366 AB (founded in 2009).
He held the title of Director at both companies.
Currently, he is a Professor at the University of Uppsala.
Previously, he worked as a Principal at The Royal Society of Chemistry and Astra Arcus AB.
Posizioni attive di Nils Martin Malmsten
| Società | Posizione | Inizio |
|---|---|---|
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Precedenti posizioni note di Nils Martin Malmsten
| Società | Posizione | Fine |
|---|---|---|
Sista versen 26366 AB
Sista versen 26366 AB Pharmaceuticals: MajorHealth Technology Discovers treatments for inflammatory disorders | Fondatore | - |
Astra Arcus AB | Corporate Officer/Principal | - |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Corporate Officer/Principal | - |
DermaGen AB
DermaGen AB Pharmaceuticals: MajorHealth Technology Develops therapeutic peptides | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Commercial Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DermaGen AB
DermaGen AB Pharmaceuticals: MajorHealth Technology Develops therapeutic peptides | Health Technology |
Astra Arcus AB | |
Sista versen 26366 AB
Sista versen 26366 AB Pharmaceuticals: MajorHealth Technology Discovers treatments for inflammatory disorders | Health Technology |
















